Michele Smith

Title: Michele Smith: Innovator in Human Insulin-Like Growth Factor Research

Introduction

Michele Smith is a notable inventor based in Poughkeepsie, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of human insulin-like growth factor binding proteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Michele Smith holds a patent for a Non-recombinant human insulin-like growth factor binding protein concentrate. This patent describes a human insulin-like growth factor (IGF) binding protein stock solution and a method for its production. The solution includes a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. Additionally, a kit is included that features a set of calibrators for nr-IGFBP-3, which contains the protein in various concentrations.

Career Highlights

Michele Smith is currently associated with Siemens Healthcare Diagnostics GmbH, where he continues to advance his research and development efforts. His work at Siemens has allowed him to collaborate with other professionals in the field, enhancing the impact of his innovations.

Collaborations

Some of Michele's coworkers include Seema Sinha and Ryan Spears. Their collaboration contributes to a dynamic work environment that fosters innovation and the development of new technologies.

Conclusion

Michele Smith's contributions to the field of biotechnology, particularly through his patent on human insulin-like growth factor binding proteins, highlight the critical role of inventors in advancing medical science. His work at Siemens Healthcare Diagnostics GmbH exemplifies the importance of collaboration in driving innovation forward.